127 related articles for article (PubMed ID: 14639605)
1. Analysis of gene expression profiles in human HL-60 cell exposed to cantharidin using cDNA microarray.
Zhang JP; Ying K; Xiao ZY; Zhou B; Huang QS; Wu HM; Yin M; Xie Y; Mao YM; Rui YC
Int J Cancer; 2004 Jan; 108(2):212-8. PubMed ID: 14639605
[TBL] [Abstract][Full Text] [Related]
2. Microarray-based prediction of cytotoxicity of tumor cells to cantharidin.
Efferth T
Oncol Rep; 2005 Mar; 13(3):459-63. PubMed ID: 15706417
[TBL] [Abstract][Full Text] [Related]
3. cDNA microarray analysis of the effect of cantharidin on DNA damage, cell cycle and apoptosis-associated gene expression in NCI-H460 human lung cancer cells in vitro.
Hsia TC; Yu CC; Hsu SC; Tang NY; Lu HF; Yu CS; Wu SH; Lin JG; Chung JG
Mol Med Rep; 2015 Jul; 12(1):1030-42. PubMed ID: 25815777
[TBL] [Abstract][Full Text] [Related]
4. The effect of cantharidins on leukemic stem cells.
Dorn DC; Kou CA; Png KJ; Moore MA
Int J Cancer; 2009 May; 124(9):2186-99. PubMed ID: 19123473
[TBL] [Abstract][Full Text] [Related]
5. Cantharidic acid induces apoptosis of human leukemic HL-60 cells via c-Jun N-terminal kinase-regulated caspase-8/-9/-3 activation pathway.
Wang SC; Chow JM; Chien MH; Lin CW; Chen HY; Hsiao PC; Yang SF
Environ Toxicol; 2018 Apr; 33(4):514-522. PubMed ID: 29345422
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional responses to cantharidin, a protein phosphatase inhibitor, in Arabidopsis thaliana reveal the involvement of multiple signal transduction pathways.
Bajsa J; Pan Z; Duke SO
Physiol Plant; 2011 Oct; 143(2):188-205. PubMed ID: 21668865
[TBL] [Abstract][Full Text] [Related]
7. The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
Xu MD; Liu SL; Zheng BB; Wu J; Wu MY; Zhang Y; Gong FR; Tao M; Zhang J; Li W
Pancreatology; 2018 Oct; 18(7):822-832. PubMed ID: 30201439
[TBL] [Abstract][Full Text] [Related]
8. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
Zhu M; Shi X; Gong Z; Su Q; Yu R; Wang B; Yang T; Dai B; Zhan Y; Zhang D; Zhang Y
Pharmacol Res; 2020 Aug; 158():104868. PubMed ID: 32407961
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells.
Minderman H; Conroy JM; O'Loughlin KL; McQuaid D; Quinn P; Li S; Pendyala L; Nowak NJ; Baer MR
Mol Cancer Ther; 2005 Jun; 4(6):885-900. PubMed ID: 15956246
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis.
Song JH; Kim JM; Kim SH; Kim HJ; Lee JJ; Sung MH; Hwang SY; Kim TS
Life Sci; 2003 Aug; 73(13):1705-19. PubMed ID: 12875902
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of cantharidin in tumor cells.
Kadioglu O; Kermani NS; Kelter G; Schumacher U; Fiebig HH; Greten HJ; Efferth T
Biochem Pharmacol; 2014 Feb; 87(3):399-409. PubMed ID: 24231507
[TBL] [Abstract][Full Text] [Related]
13. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.
Ren Y; Kinghorn AD
Bioorg Med Chem; 2021 Feb; 32():116012. PubMed ID: 33454654
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray.
Zeng F; Hon CC; Sit WH; Chow KY; Hui RK; Law IK; Ng VW; Yang XT; Leung FC; Wan JM
Int J Oncol; 2005 Aug; 27(2):513-23. PubMed ID: 16010435
[TBL] [Abstract][Full Text] [Related]
15. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of human promyelocytic leukemia cell lines exposed to volatile organic compounds.
Sarma SN; Kim YJ; Ryu JC
Toxicology; 2010 May; 271(3):122-30. PubMed ID: 20359517
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
[TBL] [Abstract][Full Text] [Related]
19. Molecular modes of action of cantharidin in tumor cells.
Efferth T; Rauh R; Kahl S; Tomicic M; Böchzelt H; Tome ME; Briehl MM; Bauer R; Kaina B
Biochem Pharmacol; 2005 Mar; 69(5):811-8. PubMed ID: 15710358
[TBL] [Abstract][Full Text] [Related]
20. Analysis of common gene expression patterns in four human tumor cell lines exposed to camptothecin using cDNA microarray: identification of topoisomerase-mediated DNA damage response pathways.
Guo X; Zhang J; Fu X; Wei Q; Lu Y; Li Y; Yin G; Mao Y; Xie Y; Rui Y; Ying K
Front Biosci; 2006 May; 11():1924-31. PubMed ID: 16368568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
